+ What Is a Non-Disclosure Agreement (NDA)? A Practical Guide for Innovators

What Is a Non-Disclosure Agreement (NDA)?

Siert Bruins Siert Bruins is the author of this webpage
Learn what a Non-Disclosure Agreement (NDA) is

Ideas, inventions and business opportunities are often discussed long before they are protected by patents, copyrights or other formal intellectual property rights. During these early conversations, innovators face a common challenge: how can you share enough information to explore a collaboration without losing control of valuable knowledge?

A Non-Disclosure Agreement (NDA), sometimes called a Confidentiality Agreement, is one of the most widely used legal tools for protecting confidential information. NDAs are commonly used by inventors, startups, researchers, consultants and companies whenever sensitive information needs to be shared with another party.

However, NDAs are frequently misunderstood. Many people assume an NDA provides complete protection for an idea, while others discover too late that an NDA is not always practical or enforceable in every situation. Understanding when an NDA works—and when it doesn't—is just as important as having the agreement itself.

This guide explains the fundamentals of NDAs, their role in protecting innovation, and how they fit into a broader intellectual property strategy.

What Is an NDA?

A Non-Disclosure Agreement (NDA), also known as a Confidentiality Agreement (CDA), is a legal contract that requires one or more parties to keep specified information confidential. It allows people and organizations to discuss ideas, technologies, research results or business opportunities while reducing the risk that sensitive information will be disclosed or used without permission.

NDAs are commonly used during the early stages of innovation, when valuable knowledge often exists long before patents are filed or products reach the market. Inventors may use an NDA before discussing an invention with a potential manufacturer, startups may ask development partners to sign one before sharing technical specifications, and researchers frequently rely on NDAs when collaborating with companies or exchanging unpublished results.

An NDA does not create intellectual property rights, nor does it replace patents, copyrights or trademarks. Instead, it protects the confidentiality of information that already has value because it is not publicly known. Once confidential information becomes public through publication, an unrestricted presentation or another unauthorized disclosure, an NDA generally cannot restore that secrecy.

For that reason, NDAs are often one part of a broader intellectual property strategy. They help innovators maintain control over valuable knowledge while evaluating partnerships, attracting investors, negotiating commercial agreements or preparing a patent application.

Key takeaway

An NDA protects confidential information—not ideas simply because they are good ideas. Its purpose is to preserve secrecy while allowing parties to communicate, collaborate and evaluate opportunities under clearly defined conditions.

An NDA is not a substitute for trust, good documentation or a well-designed IP strategy. It is simply one of the legal tools that helps innovators manage risk while sharing valuable knowledge.

What Information Can an NDA Protect?

An NDA can protect almost any type of information, provided that it is confidential, has commercial or strategic value, and is clearly identified as protected information. The agreement itself does not determine whether information is valuable—it simply creates a legal obligation for the receiving party to keep that information confidential and to use it only for the agreed purpose.

In technology development and innovation projects, confidential information may include technical know-how, unpublished inventions, software source code, algorithms, engineering drawings, prototype designs, manufacturing processes, research data, business plans, customer information, pricing strategies, and financial projections. In many cases, the real value of a company lies not in a single patent, but in a combination of confidential knowledge that competitors cannot easily reproduce.

For an NDA to be effective, the information should normally not already be in the public domain. Information that is published in scientific journals, presented without confidentiality restrictions, disclosed in a patent application, or otherwise publicly available can generally no longer be protected as confidential information under an NDA.

Many well-drafted NDAs therefore include a clear definition of what constitutes Confidential Information, together with specific exclusions. Typical exclusions include information that was already publicly known, independently developed by the receiving party, or lawfully obtained from another source without confidentiality obligations.

Examples of information commonly protected by NDAs

  • Unpublished inventions and patentable concepts
  • Software source code and algorithms
  • Research results and laboratory data
  • Engineering drawings and product specifications
  • Business plans and commercialization strategies
  • Customer lists, pricing models and financial information
  • Manufacturing processes and technical know-how
  • Trade secrets and other proprietary information

An NDA protects the confidentiality of this information—not ownership of the intellectual property itself. If your goal is to secure exclusive legal rights over an invention, you may also need patent protection or another form of intellectual property. Likewise, when physical research materials such as biological samples, chemical compounds or prototype components are transferred, a Material Transfer Agreement (MTA) may be more appropriate than an NDA alone.

When Should You Use an NDA?

An NDA is most useful whenever you need to share confidential information with another party before that information is publicly disclosed or otherwise protected. Its primary purpose is to create a clear legal obligation that confidential information may only be used for a specific purpose and may not be disclosed to others without permission.

In practice, NDAs are commonly used during the early stages of innovation, when inventors and startups are exploring commercial opportunities but are not yet ready to file a patent application or publicly launch their technology. At this stage, confidential discussions are often necessary to evaluate technical feasibility, manufacturing options, business partnerships or investment opportunities.

Typical situations where an NDA may be appropriate include:

  • Discussing an invention with a potential commercial partner.
  • Sharing technical information with suppliers or manufacturers.
  • Working with external software developers or engineering consultants.
  • Collaborating with research organizations or other companies.
  • Exchanging confidential business information during acquisition or licensing discussions.
  • Sharing unpublished research results with selected third parties.

However, an NDA should not be viewed as a standard document that everyone signs automatically. In some situations, requesting an NDA may be entirely appropriate, while in others it may be impractical or even counterproductive. Understanding the context—and the expectations of the parties involved—is just as important as having a well-written agreement.

Practical advice

Use an NDA when confidential information must be shared to evaluate a genuine business or technical opportunity. If no confidential information needs to be disclosed, or if the receiving party routinely refuses to sign NDAs—such as many professional investors—you may need to consider alternative ways to protect your innovation.

When an NDA May Not Be the Best Solution

If you've developed a promising invention, your first instinct may be to ask everyone to sign an NDA before you tell them anything. That reaction is understandable. After all, you've invested time, creativity and perhaps years of research into your idea, and you don't want someone else to benefit from it.

However, an NDA is not a universal solution. In some situations it offers excellent protection, while in others it may provide little practical value—or the other party may simply refuse to sign one. Knowing when an NDA is appropriate is just as important as knowing how to write one.

For example, many professional investors rarely sign NDAs when entrepreneurs pitch new business ideas. They review hundreds of opportunities every year and want to avoid future legal disputes if they later invest in a company with a similar concept. Likewise, large corporations sometimes have internal policies that prevent employees from signing NDAs during an initial exploratory conversation.

You should also remember that an NDA only protects information that remains confidential. Once you publish your invention, present it without confidentiality restrictions, or otherwise make it publicly available, an NDA can no longer restore that secrecy. If your invention may be patentable, filing a patent application before making a public disclosure is often the better strategy.

Finally, an NDA is only as effective as your ability to identify what is confidential and, if necessary, enforce the agreement. Litigation can be expensive and time-consuming. In many cases, careful planning, selective disclosure and a well-designed intellectual property strategy provide stronger protection than relying on an NDA alone.

Key takeaway

Don't ask yourself "Should I always use an NDA?" Instead, ask "Is an NDA the right tool for this specific situation?" The answer depends on who you are talking to, what information you need to share, and how you plan to protect your innovation in the long term.

Types of NDAs: One-Way and Mutual Agreements

Not all NDAs are the same, and when you first encounter one, it can be confusing to see different versions of what seems to be the same agreement. In practice, most NDAs fall into two main categories: one-way (also called unilateral) NDAs and mutual NDAs.

A one-way NDA is used when only one party is sharing confidential information. For example, if you are an inventor or startup founder sharing your idea with a potential manufacturer or development partner, you may ask them to sign a one-way NDA. In this case, they agree to keep your information confidential, while you are not necessarily receiving sensitive information from them.

A mutual NDA works in both directions. This is used when both parties are sharing confidential information with each other. For example, during a collaboration between two companies, or in early-stage technical discussions where both sides are revealing know-how, prototypes or business information.

In theory, the distinction sounds simple. In practice, however, the choice between a one-way and mutual NDA often depends more on the situation and the balance of information being shared than on strict legal categories. Many companies have standard preferences, and in some cases they will only agree to one type of NDA.

As an innovator, it's important to understand this distinction, but even more important is to ask yourself a practical question: who is actually disclosing valuable information in this conversation? That answer usually determines which type of NDA is appropriate.

Key takeaway

One-way NDAs protect information flowing in one direction. Mutual NDAs protect information flowing in both directions. The right choice depends on how balanced the exchange of confidential information really is—not just on what the document is called.

NDAs, Trade Secrets and Intellectual Property

An NDA is often the first layer of protection in innovation, but it is important to understand what it does—and what it does not do—in relation to intellectual property rights. An NDA protects confidentiality, meaning it helps prevent others from disclosing or using your information without permission. However, it does not create ownership of an invention or automatically grant you exclusive rights.

In practice, confidential information protected by an NDA may later become a trade secret if it remains undisclosed and is actively protected within a company. If the goal is to obtain exclusive legal rights over an invention, such as the right to prevent others from using it even if they independently develop it, then a patent may be required.

This is why NDAs are often used in the early stages of innovation, while inventors are still deciding whether to keep information as a trade secret, file a patent application, or explore commercial partnerships.

Should Investors Sign an NDA?

If you're preparing to pitch your idea to investors, you may assume that an NDA should always be signed first. In reality, this is often not the case. Most professional investors do not sign NDAs for early-stage pitches, mainly because they evaluate a large number of ideas and need to avoid potential conflicts if they later invest in a similar space.

As an entrepreneur, this can feel counterintuitive. You may be sharing something you believe is highly valuable, but investors typically make decisions based on execution, market potential and team strength rather than the idea alone. This means that in many cases, you will need to share your concept without an NDA in place.

Understanding this dynamic helps you focus on what really matters in fundraising: clarity, validation and traction, rather than relying on confidentiality agreements as a precondition for discussion.

NDAs and Patent Protection

NDAs and patents often interact in early-stage innovation, but they serve very different purposes. An NDA keeps information confidential, while a patent gives you legal exclusivity over an invention once it has been granted.

For many inventors, timing is critical. Public disclosure of an invention can destroy its patentability in many jurisdictions, meaning that once information is made public, it may no longer qualify for patent protection. This is why NDAs are often used before discussing an invention with external parties while a patent application is being prepared.

However, it is important to understand that an NDA is not a substitute for a patent. It cannot prevent others from independently developing the same invention, nor does it provide the same level of legal protection as a granted patent.

Common Mistakes When Using NDAs

One of the most common mistakes is assuming that an NDA provides complete protection for an idea. In reality, NDAs only protect confidential information under specific conditions and do not prevent independent development or reverse engineering.

Another frequent mistake is using NDAs too early or too broadly. If you ask every potential contact to sign an NDA, you may limit valuable discussions, especially with investors or larger companies that have strict policies around confidentiality agreements.

A third mistake is failing to clearly define what is considered confidential. If an NDA is too vague, it can be difficult to enforce and may create misunderstandings rather than clarity.

Practical Next Steps: From NDA to Patent Protection

Once you understand what an NDA is and when to use it, the next question is often what to do with the information you are trying to protect. In many cases, an NDA is only the first step in a broader innovation strategy.

If you are ready to work with NDAs in practice, you can also use our NDA template and guide, which shows you what clauses to include and how to structure a strong confidentiality agreement.

To understand how NDAs fit into a broader innovation strategy, it helps to distinguish them from formal intellectual property rights such as patents, copyrights and trade secrets. An NDA protects confidentiality, while intellectual property law defines who ultimately owns and controls the results of innovation. You can read more about this in our guide to intellectual property rights.

If your idea or technology has potential commercial value, you may eventually want to secure stronger and more exclusive protection through a patent. A patent gives you the legal right to prevent others from using your invention, but it requires careful preparation, including a detailed description of how your invention works in practice.

Before you disclose your invention to external parties, it is often important to think about timing: sharing too early without protection may limit your options later, while waiting too long may slow down collaboration or development. Understanding how NDAs and patents interact can help you make better strategic decisions at this stage.

To explore this further, you can read our guide on how to get a patent, which explains the patenting process in detail and when it makes sense to move from confidentiality protection to formal intellectual property rights.

Key takeaway

An NDA helps you safely share information. A patent helps you secure exclusive rights. Knowing when to move from one to the other is a key part of building and protecting any innovation.

Explore More: Trade Secrets and NDAs in Practice

If you want to explore how NDAs are used in real-world innovation and startup situations, including trade secrets, collaboration scenarios and practical examples, you can visit our overview page on Trade Secrets & NDAs.

About Siert Bruins

Siert Bruins, PhD

Hello! I'm Siert Bruins, a Dutch entrepreneur and founder of Life2Ledger B.V. . Trained as a Medical Biologist, I hold a PhD in Clinical Diagnostics from the University of Groningen and have over two decades of hands-on experience in innovation at the intersection of universities, hospitals and technology-driven companies.

Throughout my career, I have (co)-founded several life science startups and helped researchers, inventors, and early-stage founders transform their ideas into prototypes, patents, partnerships, and funded projects. My work spans medical device development, clinical validation, startup strategy, and technology transfer. I've guided innovations from the initial sketch to licensing agreements and investment negotiations.

Since 2009, I've run the Dutch version of this site. I launched to provide founders worldwide with practical, experience-based guidance on inventions, patents, valuation and raising startup capital. Today, in Life2Ledger, I also focus on blockchain-based data validation for AI in healthcare — Specifically: how can you be sure that your AI is trained and validated on the correct data, and that this data truly comes from the patient and the device you think it does?

The content on this site is based on my own experience with real startups — real negotiations, real decisions, and real outcomes. Yes, I use tools to support the writing process, but the insights, structure, and conclusions are my own. This is not generic content, but a reflection of what actually happens behind the scenes.

Want to connect? Visit my LinkedIn or follow me on X. Have questions about your startup strategy or patents? Reach out and I'll share practical insights from real-world experience.